Sodium Polystyrene Sulfonate
Sodium Polystyrene Sulfonate Powder for Suspension Cation - Exchange Resin Rx only
Approved
Approval ID
af0a64e1-4fde-4320-93a7-7801a03b7613
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 11, 2021
Manufacturers
FDA
ATLANTIC BIOLOGICALS CORP.
DUNS: 047437707
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Sodium Polystyrene Sulfonate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code17856-0831
Application NumberANDA090313
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sodium Polystyrene Sulfonate
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateJune 10, 2021
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR